BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 25993563)

  • 1. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006258. PubMed ID: 25993563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
    Rabindranath KS; Strippoli GF; Daly C; Roderick PJ; Wallace S; MacLeod AM
    Cochrane Database Syst Rev; 2006 Oct; (4):CD006258. PubMed ID: 17054289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials.
    Nistor I; Palmer SC; Craig JC; Saglimbene V; Vecchio M; Covic A; Strippoli GF
    Am J Kidney Dis; 2014 Jun; 63(6):954-67. PubMed ID: 24434188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review.
    Rabindranath KS; Strippoli GF; Roderick P; Wallace SA; MacLeod AM; Daly C
    Am J Kidney Dis; 2005 Mar; 45(3):437-47. PubMed ID: 15754266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials.
    Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ
    Am J Kidney Dis; 2014 Jun; 63(6):968-78. PubMed ID: 24685515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration.
    Tian JH; Ma B; Yang K; Liu Y; Tan J; Liu TX
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD006819. PubMed ID: 25740673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
    Blankestijn PJ; Fischer KI; Barth C; Cromm K; Canaud B; Davenport A; Grobbee DE; Hegbrant J; Roes KC; Rose M; Strippoli GF; Vernooij RW; Woodward M; de Wit GA; Bots ML
    BMJ Open; 2020 Feb; 10(2):e033228. PubMed ID: 32029487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive agents for treating IgA nephropathy.
    Vecchio M; Bonerba B; Palmer SC; Craig JC; Ruospo M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2015 Aug; (8):CD003965. PubMed ID: 26235292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial interventions for preventing and treating depression in dialysis patients.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
    Peters SA; Bots ML; Canaud B; Davenport A; Grooteman MP; Kircelli F; Locatelli F; Maduell F; Morena M; Nubé MJ; Ok E; Torres F; Woodward M; Blankestijn PJ;
    Nephrol Dial Transplant; 2016 Jun; 31(6):978-84. PubMed ID: 26492924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidants for chronic kidney disease.
    Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Evidence in Haemodiafiltration.
    Locatelli F; Violo L; Longhi S; Del Vecchio L
    Blood Purif; 2015; 40 Suppl 1():24-9. PubMed ID: 26344510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
    Hahn D; Cody JD; Hodson EM
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003895. PubMed ID: 24872328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents for treating IgA nephropathy.
    Natale P; Palmer SC; Ruospo M; Saglimbene VM; Craig JC; Vecchio M; Samuels JA; Molony DA; Schena FP; Strippoli GF
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD003965. PubMed ID: 32162319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation.
    Klingel R; Schaefer M; Schwarting A; Himmelsbach F; Altes U; Uhlenbusch-Körwer I; Hafner G
    Nephrol Dial Transplant; 2004 Jan; 19(1):164-70. PubMed ID: 14671052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.